Boston Scientific Corporation (BSX.F) XETRA

92.60

+1.4(+1.54%)

Updated at September 08 09:57PM

Currency In EUR

Boston Scientific Corporation

Address

300 Boston Scientific Way

Marlborough, MA 01752-1234

United States of America

Phone

508 683 4000

Sector

Healthcare

Industry

Medical - Devices

Employees

53000

First IPO Date

January 03, 2000

Key Executives

NameTitlePayYear Born
Mr. Michael F. MahoneyChairman, President & Chief Executive Officer4.77M1965
Mr. Jeffrey B. Mirviss M.B.A.Executive Vice President & President of Peripheral Interventions1.34M1966
Mr. Arthur Crosswell ButcherExecutive Vice President and Group President of MedSurg & Asia Pacific1.52M1971
Mr. Joseph M. FitzgeraldExecutive Vice President & Group President of Cardiology1.96M1964
Mr. Daniel J. Brennan CPAExecutive Vice President & Chief Financial Officer2.09M1966
Mr. Vance R. Brown J.D.Senior Vice President, General Counsel & Corporate Secretary01970
Mr. John Bradley SorensonExecutive Vice President of Global Operations01968
Ms. Jodi Euerle EddySenior Vice President and Chief Information & Digital Officer01973
Mr. Jonathan R. MonsonSenior Vice President of Investor Relations0N/A
Ms. Emily M. WoodworthSenior Vice President, Global Controller & Chief Accounting Officer01978

Description

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through MedSurg and Cardiovascular segments. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, that uses in the treatment of coronary artery disease and aortic valve conditions. Further, it provides stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems to treat arterial and venous diseases; and peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.